PR-104 plus sorafenib in patients with advanced hepatocellular carcinoma
Titel:
PR-104 plus sorafenib in patients with advanced hepatocellular carcinoma
Auteur:
Abou-Alfa, Ghassan K. Chan, Stephan L. Lin, Chia-Chi Chiorean, E. Gabriela Holcombe, Randall F. Mulcahy, Mary F. Carter, William D. Patel, Kashyap Wilson, William R. Melink, Teresa J. Gutheil, John C. Tsao, Chao-Jung